Details for New Drug Application (NDA): 077714

NDA 077714 describes TERBINAFINE HYDROCHLORIDE, which is a drug marketed by Taro, Aurobindo Pharma, Breckenridge Pharm, Chartwell, Cipla, Dr Reddys Labs Inc, Emed Medcl, Gedeon Richter Usa, Glenmark Pharms Ltd, Heritage Pharma Avet, Invagen Pharms, Mylan, Natco Pharma, Orbion Pharms, Roxane, and Wockhardt, and is included in sixteen NDAs. It is available from forty-two suppliers. Additional details are available on the TERBINAFINE HYDROCHLORIDE profile page.

The generic ingredient in TERBINAFINE HYDROCHLORIDE is terbinafine hydrochloride. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the terbinafine hydrochloride profile page.

Summary for 077714

Tradename:	TERBINAFINE HYDROCHLORIDE
Applicant:	Breckenridge Pharm
Ingredient:	terbinafine hydrochloride
Patents:	0

Pharmacology for NDA: 077714

Suppliers and Packaging for NDA: 077714

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077714	ANDA	PD-Rx Pharmaceuticals, Inc.	43063-906	43063-906-20	20 TABLET in 1 BOTTLE, PLASTIC (43063-906-20)
TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077714	ANDA	PD-Rx Pharmaceuticals, Inc.	43063-906	43063-906-42	42 TABLET in 1 BOTTLE, PLASTIC (43063-906-42)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 250MG BASE
Approval Date:	Jun 4, 2010	TE:	AB	RLD:	No

Complete Access Available with Subscription